Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
67.80    3.20 (4.95%)
Bid:
65.00
Ask:
66.40
Spread: 1.40 (2.154%)
Market Cap: £105.41m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Disposal & trading update

12 Jan 2006 09:21

Macfarlane Group PLC12 January 2006 Macfarlane Group PLC("Macfarlane" or "Group") Macfarlane Group PLC to dispose of its Hungarian operations In line with the Group's strategy to concentrate on and develop its corebusinesses, Macfarlane Group PLC ("Macfarlane") announces that it has todayconcluded an agreement to sell its Hungarian packaging manufacture and assemblyoperation, Macfarlane Packaging Kft to Nefab AB, a Swedish based company, for atotal cash consideration of £2.3 million after attributable expenses. £2.1million of the consideration will be paid immediately, with the retainedconsideration becoming payable in March 2008. The proceeds will be used tofurther reduce Group borrowings. The gross assets disposed of were £1.9 million (unaudited) at 31 December 2005and the net assets being sold totalled £1.4 million at the same date. Thebusiness made an operating profit of £0.7 million on turnover of £3.6 million inthe year to 31 December 2005 (unaudited). The Directors estimate that thedisposal will produce a realised gain of £0.9 million in the current financialyear to 31 December 2006. Trading update In advance of the Group's preliminary statement of final results for the year to31 December 2005, to be released on 28th March 2006, Macfarlane is pleased togive the following update. The Board's expectations as to trading results for 2005, prior to net propertygains, remain broadly unchanged. Despite unfavourable market conditions, themomentum in the Group's recovery plan has continued in the second half of 2005. Two years ago, the Board indicated that nothing would be allowed to interferewith the establishment of the strongest possible platform for recovery andreturn to profitability. The Board does not underestimate the challenges ahead.However the business is now positioned for growth and the Board anticipates afurther significant improvement in trading results and cash generation in 2006.In the light of this progress, the Board will outline its objectives fordividend policy prior to the Annual General Meeting in May 2006. Further information:Archie S. Hunter Chairman 0141 333 9666Peter D. Atkinson Chief Executive 0141 333 9666John Love Finance Director 0141 333 9666 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Feb 20247:00 amRNSAnnual Results 2023
26th Feb 20241:46 pmRNSInvestor Presentation via Investor Meet Company
14th Feb 202410:29 amRNSNotice of Results
13th Dec 202310:00 amRNSBoard Changes
23rd Nov 20237:00 amRNSTrading Update
31st Oct 20238:19 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSAcquisition of B&D 2010 Group Limited
29th Aug 20237:00 amRNSIssue of Shares
24th Aug 20237:00 amRNSHalf-year Report
8th Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
4th Aug 20237:00 amRNSNotice of Results
6th Jul 20231:29 pmRNSHolding(s) in Company
9th May 20233:08 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Trading Update
2nd May 20237:00 amRNSAcquisition
28th Apr 20235:17 pmRNSNotice of AGM
20th Apr 20235:18 pmRNSHolding(s) in Company
20th Apr 20232:03 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSAnnual Report 2022
27th Mar 202312:29 pmRNSDirector/PDMR Shareholding
6th Mar 20237:00 amRNSAcquisition
23rd Feb 20237:00 amRNSAnnual Results 2022
15th Feb 20237:00 amRNSNotice of Results
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSDirector/PDMR Shareholding
24th Nov 20227:00 amRNSTrading Update
7th Oct 202210:00 amRNSHolding(s) in Company
7th Oct 202210:00 amRNSHolding(s) in Company
27th Sep 20221:57 pmRNSHolding(s) in Company
15th Sep 20227:00 amRNSAppointment of Non-Executive Director
8th Sep 20227:00 amRNSDirector/PDMR Shareholding
25th Aug 20227:16 amRNSHalf-year Report
5th Aug 20227:00 amRNSNotice of Results
19th May 20227:00 amRNSDirector/PDMR Shareholding
17th May 202212:00 pmRNSAcquisition
16th May 20227:00 amRNSIssue of Shares
10th May 20223:24 pmRNSResult of AGM
10th May 202212:00 pmRNSTrading Update
6th Apr 20227:00 amRNSNotice of AGM
5th Apr 20227:00 amRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Report 2021
25th Mar 20224:12 pmRNSDirector/PDMR Shareholding
11th Mar 20223:41 pmRNSDirector/PDMR Shareholding
24th Feb 20221:00 pmRNSDividend Payment Date
24th Feb 20227:00 amRNSFinal Results
11th Feb 20227:00 amRNSNotice of Results
4th Jan 20227:00 amRNSDisposal
25th Nov 20217:00 amRNSTrading Update
18th Nov 202110:17 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.